Abstract
1. Explore new technologies/equipment for in vitro release testing of novel dosage forms 2. Provide a forum to discuss the specification-setting process 3. Identify current method development problems and the associated dosage forms—share solutions to these difficult problems 4. Explore the use of dissolution testing in applying the BCS/biowaivers 5. Explore in vitro release testing methods for dosage forms other than solid oral dosage forms 6. Discuss the calibration parameters of all official apparatus. 7. Explore how the test may be more relevant to the human physiology 8. Discuss validation principles for new and standard methods 9. Explore harmonization of ICH and Pharmacopeias 10. Evaluate statistics and modeling related to in vitro release and dissolution testing
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
